EUCTR2015-003395-72-DE进行中（未招募）1 期
Vitamin D in secondary prevention of benign paroxysmal positional vertigo: a prospective, multicenter, randomized, placebo-controlled, double-blind study (VitD@BPPV) - Vitamin D in secondary prevention of BPPV
Hospital of the University of Munich0 个研究点目标入组 219 人开始时间: 2016年7月21日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 219
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Written informed consent to participation in the study
- •- Age = 18 years
- •- Patients with BPPV of the posterior, horizontal or anterior semicircular canal (confirmed by diagnostic maneuvers) of different etiologies (idiopathic, traumatic, other vestibular diseases)
- •- The ability to follow study instructions and likely to attend and complete all visit
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 59
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 160
排除标准
- •- Osteoporosis
- •- Hyper-/Hypocalcemia
- •- Hyper-/Hypophosphatemia
- •- Hypercalcuria
- •- Uro-/Nephrolithiasis in medical history
- •- Intake of vitamin D-metabolites/-analogues
- •- Intake of cardiac glycosides
- •- Sarkoidosis
- •- Active or intended pregnancy
- •- Hereditary fructose intolerance, glucose-galactose malabsorption, sucrase-isomaltase deficiency, congenital galactose intolerance, congenital lactase deficiency
- •- Pseudohypoparathyreodism
- •- Life threatening disease with statistical life expectancy < 12 months
- •- Former participation in this study or participation in a clinical trial with intake of an investigational drug within the last 30 days before participation in this study
研究者
相似试验
进行中（未招募）
3 期
Vitamin D in secondary prevention of benign paroxysmal positional vertigo: a prospective, multicenter, randomized, placebo-controlled, double-blind studyH81.1Benign paroxysmal vertigoDRKS00011827Deutsches Schwindel- und Gleichgewichtszentrum DSGZ und Neurologische Klinik, Klinikum der Universität München59
招募中
2 期
: Prophylactic effect of vitamin D supplementation in the prevention of atrial fibrillation after coronary artery bypass grafting : Randomized Clinical TrialParoxysmal atrial fibrillationIRCT20201028049175N4Arak University of Medical Sciences90
已完成
不适用
The effect of vitamin D on the treatment of gestational diabetesIRCT20130311012782N34Shahid Beheshti University of Medical Sciences100
撤回
不适用
Efficacy of vitamin D supplementation in preventing peripheral neuropathy in multiple myeloma patients.neuralgia1002532010034606Peripheral neuropathyNL-OMON43187Medisch Centrum Leeuwarden52
进行中（未招募）
不适用
Vitamin D supplementation for prevention of placenta mediated pregnancy complications. - Prevention of pregnancy complications with vitamin DWe will try to prevent preeclampsia, groth restriction and prematurity by vitamin D supplementation given as one dose in mid pregnancyMedDRA version: 12.1Level: LLTClassification code 10036485Term: Pre-eclampsiaMedDRA version: 12.1Level: LLTClassification code 10036590Term: Premature babyMedDRA version: 12.1Level: LLTClassification code 10053759Term: Growth retardationEUCTR2010-019483-37-SEKarolinska University Hospital